Health and biomedical sciences

BRIDGE funds projects at the interface between basic research and science-based innovation that have the potential to develop an innovative product or service.

BRIDGE is a joint program of the Swiss National Science Foundation and Innosuisse.

The goal is to bundle nationally funded research projects into pan-European networks (COST Actions) across all science and technology fields.

COST generally does not fund research but provides support for the networking activities within the COST Actions. The SNSF, the Swiss COST Coordinator, has limited funds available for research.

Note: Swiss participation depends on the COST Action.

The goal is to coordinate research and innovation activities to address Europe’s most pressing challenges. The European Partnerships are joint initiatives between the EU, national authorities and/or the private sector:

Fostering a European Research Area for Health Research (Era4Health); Innovative Health Initiative (IHI); European and Developing Countries Clinical Trials Partnership (EDCTP 3); One Health Antimicrobial Resistance (OH AMR); Pandemic Preparedness; Personalised Medicine (EP PerMed); Rare Diseases; Transforming Health and Care Systems (THCS).
See also: EIT Health.

Note: Swiss participation and funding depends on the partnership.

Eureka supports market-oriented projects between companies, research institutes and universities in order to strengthen Europe's competitiveness.

Eurostars, a joint program of Eureka and the European Commission, specifically supports innovative SMEs that want to develop new products, processes or services for commercialisation in cross-border collaborations.

Note: Swiss participation is funded by Innosuisse.

The goal is to support frontier research on the complex mechanisms of living organisms. HFSP supports research projects and research fellowships, with particular emphasis on interdisciplinary and high-risk projects.

HFSP is financed by the member countries and the EU.

The federal government initiates and supports scientific research that deals with societal problems in 11 policy areas: health, social security, environment, agriculture, energy, sustainable spatial development and mobility, development and cooperation, security and peace policy, vocational training, sport and exercise, and sustainable transport. Some federal offices also fund research in other areas.

The goal is to promote the development of personalized medicine and personalized health in Switzerland.

SPHN is an initiative of the Swiss Academy of Medical Sciences and is financed by the Swiss government as well as with matching funds from the participating institutions.

CDMRP fosters novel approaches in biomedical research that will lead to new treatment methods, improvements in patient care, or breakthrough technologies and resources of clinical benefit. It funds basic research as well as clinical projects on a range of topics of relevance to the health of US army personnel and the general public.

NIH supports research into the nature and behavior of living systems in order to enhance health, lengthen life, and reduce illness and disability.

NIH is a US government agency and the major source of funding in the USA for biomedical and health-related research.

Note: Swiss participation depends on the call.